BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33801927)

  • 1. Inhibition of NUPR1-Karyopherin β1 Binding Increases Anticancer Drug Sensitivity.
    Park C; Oh J; Lee WM; Koh HR; Sohn UD; Ham SW; Oh K
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of KPNB1 as a Cellular Target of Aminothiazole Derivatives with Anticancer Activity.
    Kim YH; Ha S; Kim J; Ham SW
    ChemMedChem; 2016 Jul; 11(13):1406-9. PubMed ID: 27241026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells.
    Stelma T; Leaner VD
    Oncotarget; 2017 May; 8(20):32833-32847. PubMed ID: 28427184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
    Clark DW; Mitra A; Fillmore RA; Jiang WG; Samant RS; Fodstad O; Shevde LA
    Curr Cancer Drug Targets; 2008 Aug; 8(5):421-30. PubMed ID: 18690848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.
    Lan W; Santofimia-Castaño P; Swayden M; Xia Y; Zhou Z; Audebert S; Camoin L; Huang C; Peng L; Jiménez-Alesanco A; Velázquez-Campoy A; Abián O; Lomberk G; Urrutia R; Rizzuti B; Geli V; Soubeyran P; Neira JL; Iovanna J
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32780723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.
    Emma MR; Iovanna JL; Bachvarov D; Puleio R; Loria GR; Augello G; Candido S; Libra M; Gulino A; Cancila V; McCubrey JA; Montalto G; Cervello M
    Cell Death Dis; 2016 Jun; 7(6):e2269. PubMed ID: 27336713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Characterization of Nupr1L, A Novel p53-Regulated Isoform of the High-Mobility Group (HMG)-Related Protumoral Protein Nupr1.
    Lopez MB; Garcia MN; Grasso D; Bintz J; Molejon MI; Velez G; Lomberk G; Neira JL; Urrutia R; Iovanna J
    J Cell Physiol; 2015 Dec; 230(12):2936-50. PubMed ID: 25899918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KPNB1-mediated nuclear import in cancer.
    Shi Q; Lin M; Cheng X; Zhang Z; Deng S; Lang K; Yang Z; Sun X
    Eur J Pharmacol; 2023 Sep; 955():175925. PubMed ID: 37473981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.
    Malugin A; Kopecková P; Kopecek J
    J Control Release; 2007 Dec; 124(1-2):6-10. PubMed ID: 17869367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance.
    Vincent AJ; Ren S; Harris LG; Devine DJ; Samant RS; Fodstad O; Shevde LA
    FEBS Lett; 2012 Sep; 586(19):3429-34. PubMed ID: 22858377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUPR1 and its potential role in cancer and pathological conditions (Review).
    Martin TA; Li AX; Sanders AJ; Ye L; Frewer K; Hargest R; Jiang WG
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Karyopherin beta 1 suppresses prostate cancer growth.
    Yang J; Guo Y; Lu C; Zhang R; Wang Y; Luo L; Zhang Y; Chu CH; Wang KJ; Obbad S; Yan W; Li X
    Oncogene; 2019 Jun; 38(24):4700-4714. PubMed ID: 30742095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer.
    Kelenis DP; Rodarte KE; Kollipara RK; Pozo K; Choudhuri SP; Spainhower KB; Wait SJ; Stastny V; Oliver TG; Johnson JE
    Cancer Res; 2022 Sep; 82(17):3058-3073. PubMed ID: 35748745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the binding between Nupr1 and MSL1 and their DNA-repairing activity.
    Aguado-Llera D; Hamidi T; Doménech R; Pantoja-Uceda D; Gironella M; Santoro J; Velázquez-Campoy A; Neira JL; Iovanna JL
    PLoS One; 2013; 8(10):e78101. PubMed ID: 24205110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Karyopherinβ1 regulates proliferation of human glioma cells via Wnt/β-catenin pathway.
    Lu T; Bao Z; Wang Y; Yang L; Lu B; Yan K; Wang S; Wei H; Zhang Z; Cui G
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1189-97. PubMed ID: 27568288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KPNB1, XPO7 and IPO8 mediate the translocation ofNF-κB/p65 into the nucleus.
    Liang P; Zhang H; Wang G; Li S; Cong S; Luo Y; Zhang B
    Traffic; 2013 Nov; 14(11):1132-43. PubMed ID: 23906023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma.
    Santofimia-Castaño P; Xia Y; Peng L; Velázquez-Campoy A; Abián O; Lan W; Lomberk G; Urrutia R; Rizzuti B; Soubeyran P; Neira JL; Iovanna J
    Cells; 2019 Nov; 8(11):. PubMed ID: 31744261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
    Zhang Y; Li KF
    Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.
    Zhu ZC; Liu JW; Li K; Zheng J; Xiong ZQ
    Oncogene; 2018 May; 37(22):2936-2952. PubMed ID: 29520102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death.
    Hamidi T; Cano CE; Grasso D; Garcia MN; Sandi MJ; Calvo EL; Dagorn JC; Lomberk G; Urrutia R; Goruppi S; Carracedo A; Velasco G; Iovanna JL
    Clin Cancer Res; 2012 Oct; 18(19):5234-46. PubMed ID: 22899799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.